{
  "docId": "019de076-794e-71d3-9fbb-8ba3f121f554",
  "docSlug": "4ee48ed5e56c8ddc8f74aa05772c7ac4",
  "documentTitle": "Comera | Investor Presentation Deck | 16 slides",
  "authorId": "comera",
  "authorName": "Comera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 6,
  "pageCount": 16,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Includes a callout highlighting J&J's Darzalex Faspro achieving 85% conversion in under 2 years.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-794e-71d3-9fbb-8ba3f121f554/6",
  "deckHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554",
  "deckJsonHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554.json",
  "deckAnchorHref": "/decks/019de076-794e-71d3-9fbb-8ba3f121f554#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.22,
        "x": 0.75,
        "y": 0.33
      },
      "kind": "callout",
      "text": "The most recent conversion, J&J's Darzalex Faspro, has achieved 85% conversion in less than 2 years",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "afc9a866-6999-4978-a922-7ede037df5de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.45,
        "y": 0.25
      },
      "kind": "chart",
      "text": "SQ Market Penetration After IV Conversion",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17f1e25a-6936-4ec1-9898-4a0edb9cbf75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.05,
        "y": 0.46
      },
      "kind": "image",
      "text": "Industry news clippings regarding Merck and Roche",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fa5a273-8710-4578-b3d2-705b16caa268",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "list",
      "text": "Global biologics market ~$383B in 2022, growing at an 8.8% CAGR through 2032; Majority of biologics are IV infusions; Significant industry interest in converting IV biologics to SQ",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07e27cf5-47c7-4a56-8fcb-bf4b32da329e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.95,
        "x": 0.02,
        "y": 0.83
      },
      "kind": "source-note",
      "text": "Source: Symphony; FDA; Biosimilar Development; L.E.K. interviews, research and analysis...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99264aa1-ab26-4a81-87e9-c2ed0a427642",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.04,
        "y": 0.17
      },
      "kind": "title",
      "text": "SQ Value Proposition Validated by Market Conversions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70131f69-ff90-4bf5-8577-96e89e67892e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 6,
      "beatId": "f192b7d0-87c2-4c37-b6d9-2dc7cad32dc8",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The deck provides evidence and proof of the SQore platform's effectiveness.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "d0fe045e-0c5c-47f4-bb13-8b12e4725574",
      "evidence": "The deck presents the SQore platform and its advantages, using the golden circle framework.",
      "position": 1,
      "objective": "Why is Comera's SQore platform a compelling solution?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}